Viking Therapeutics, Inc.: Q1 2026 results
Published 29. 4. 2026, after the market closes. EPS -1,37 $ against an estimate of -0,91.
AI summary
AIThe summary shows how the results turned out, what the company delivered, the pros and cons and why the stock reacted the way it did. We do not have a press release for this quarter yet, so the summary would be based on the numbers alone.